IPOPLUS

1,538.7

-11.5 -0.74%

12 Jun 2026

NSE Listed

IPCA Laboratories Limited (IPCALAB)

Volume: 1,31,987Avg Vol 1W: 2,86,348.4Avg Vol 1M: 2,89,100.252W Range:1,251.61,678.3
₹1,538.7 0.74%
Key Ratios
Updated 3h ago
Market Cap₹40,232 Cr
Current Price₹1,538.7
Previous Close₹1,550.2
High / Low (52w)₹1,678.3 / ₹1,251.6
Volume1,31,987
Avg Vol (1W)2,86,348.4
Avg Vol (1M)2,89,100.2
Stock P/E118.93
Book Value₹317.85
Dividend Yield0.4%
ROE14.2%
ROA9.6%
Revenue (TTM)₹9,032 Cr
Revenue Growth16%
Profit Margin11.8%
Total Debt₹543 Cr
Shares Outstanding25 Cr
Face Value₹1
EPS (TTM)₹13.31
P/B4.99
Debt / Equity0.1
50 DMA₹1,544.57
200 DMA₹1,449.57
Day change-0.74%
Price Chart
1,538.7 13.35% · 1Y
1656127041.3L
2025-06-17
2026-06-12

20-day avg volume: 2.9L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 15% YoY.
  • Stock trades at a high P/E of 119.
Quarterly Results
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue₹2,093 Cr₹2,355 Cr₹2,245 Cr₹2,247 Cr₹2,309 Cr₹2,557 Cr₹2,393 Cr₹2,388 Cr
EBITDA₹314 Cr₹367 Cr₹385 Cr₹355 Cr₹349 Cr₹469 Cr₹446 Cr₹470 Cr
Net Profit₹192 Cr₹229 Cr₹248 Cr₹68 Cr₹233 Cr₹283 Cr₹326 Cr₹299 Cr
EPS
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹4,686 Cr₹5,483 Cr₹5,896 Cr₹6,370 Cr₹7,830 Cr₹9,032 Cr
EBITDA₹763 Cr₹1,398 Cr₹1,143 Cr₹791 Cr₹1,089 Cr₹1,421 Cr
Net Profit₹606 Cr₹1,140 Cr₹884 Cr₹471 Cr₹547 Cr₹738 Cr
EPS
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹5,260 Cr₹6,068 Cr₹7,624 Cr₹8,626 Cr₹11,101 Cr₹11,761 Cr
Total Liabilities₹1,619 Cr₹1,352 Cr₹2,082 Cr₹2,711 Cr₹3,374 Cr₹3,372 Cr
Equity₹3,641 Cr₹4,716 Cr₹5,542 Cr₹5,915 Cr₹7,727 Cr₹8,388 Cr
Total Debt₹103 Cr₹9 Cr₹395 Cr₹652 Cr₹580 Cr₹543 Cr
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹723 Cr₹1,336 Cr₹1,058 Cr₹1,029 Cr₹1,241 Cr₹1,683 Cr
Investing₹-510 Cr₹-521 Cr₹-855 Cr₹-725 Cr₹-1,292 Cr₹-869 Cr
Financing₹-137 Cr₹-306 Cr₹427 Cr₹507 Cr₹-553 Cr₹-283 Cr
Free Cash Flow₹723 Cr₹1,336 Cr₹1,058 Cr₹1,029 Cr₹1,241 Cr₹1,683 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search